Henry Waxman: The House's New Health Care Power Broker

For Big Pharma’s veteran lo lobbyists, the Presidential election ended up being a light appetizer before the main course: a run-off between two veteran Democrats for control of a key committee overseeing health care and pharmaceutical issues. Henry Waxman won.

No political development may be more important for the biopharma sector in 2008 than the ascension of California Democrat Henry Waxman to Chairman of the Energy & Commerce Committee.

Waxman won a vote of the House Democratic Caucus to unseat longstanding Chairman John Dingell (D-Mich.) on November 20.

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Market Access

More from Pink Sheet